ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | | Tissue enriched |
AKR1C2 | Aldo-keto reductase family 1, member C2 | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ASPH | Aspartate beta-hydroxylase | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
CRYZ | Crystallin, zeta (quinone reductase) | Enzymes Plasma proteins
| | | | | Expressed in all |
CYB5R1 | Cytochrome b5 reductase 1 | Enzymes
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DCXR | Dicarbonyl/L-xylulose reductase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Enzymes Plasma proteins
| | | | | Expressed in all |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Group enriched |
GPD2 | Glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HSD17B4 | Hydroxysteroid (17-beta) dehydrogenase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LDHB | Lactate dehydrogenase B | Enzymes Plasma proteins
| | | | | Expressed in all |
MDH2 | Malate dehydrogenase 2, NAD (mitochondrial) | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
NSDHL | NAD(P) dependent steroid dehydrogenase-like | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NXN | Nucleoredoxin | Enzymes
| | | | | Expressed in all |
PHGDH | Phosphoglycerate dehydrogenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
PNPO | Pyridoxamine 5'-phosphate oxidase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
POR | P450 (cytochrome) oxidoreductase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PRDX1 | Peroxiredoxin 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
PRDX2 | Peroxiredoxin 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
PRDX5 | Peroxiredoxin 5 | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
PRDX6 | Peroxiredoxin 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
SOD1 | Superoxide dismutase 1, soluble | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SOD2 | Superoxide dismutase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
TXNRD1 | Thioredoxin reductase 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
TYR | Tyrosinase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
UGDH | UDP-glucose 6-dehydrogenase | Enzymes Plasma proteins
| | | | | Expressed in all |